Joint Clinical Trials Office
Head and Neck Patient Registry
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 17, 2024
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 21, 2024
Molecular Pathogenesis of Plasma Cell Disorder
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 11, 2024
ARO-021: Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 22, 2019
A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of lutetium (177Lu) vipivotide tetraxetan in Adult Participants with Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: November 26, 2024
The Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair in Robotic Anti-Reflux Surgery: A Multi-Institutional Randomized Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 12, 2024
Long term Outcomes of Obese Patients with Gastrointestinal Complications of Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2019
Pembrolizumab and Stereotactic Radio Surgery (SRS) of Selected Brain Metastases in Breast Cancer Patients
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 5, 2019
AGCT1532: Phase 3 Accelerated BEP Trial: A Randomized Phase 3 trial of Accelerated vs Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 22, 2019
DORA Trial: Phase 3 Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 13, 2019